Delivery Order SPE2DB20D1109-SPE2DB25FP76Q
- Not listed
- The Defense Logistics Agency awarded a $16,057.06 delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, valued at $13,599.02 under firm fixed price terms. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $10,065.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 15, 2025, with an ultimate completion date of September 16, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,967.59 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a single delivery of the pharmaceutical product to support federal medical procurement needs. The performance location is identified as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $10,028.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 9, 2025, with completion expected by September 10, 2025. This non-set-aside contract represents a pharmaceutical supply delivery under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $7,677.00 delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials on September 29, 2025, with completion scheduled for September 30, 2025. This non-competitive, firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical SPE2DX contract valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $17,870.71 delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 ml vials on August 27, 2025, with completion targeted for August 28, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Bridion 200 mg/2 mL vials totaling $2,544.38 with a completion date of August 26, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 29, 2025, for Bridion 500 mg/5 mL vials, with a ceiling value of $35,252.62 under firm fixed-price terms. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,538.93 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside designation was applied to this procurement. This delivery...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP76QDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,584.61 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child delivery order under a larger contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a key distribution hub for federal medical procurement operations. This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical supply requirements across multiple therapeutic domains for military and veteran healthcare systems. The company's substantial contract portfolio with the DLA demonstrates its capability to meet competitive federal procurement standards and support critical medical supply chains for defense and civilian federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 9/16/25 |